CareLit · DOI-Nachweis · Pneumologie
Evaluating cardiac safety of tiotropium in patients with COPD: Combined analysis of Holter-ECG data from four trials
DOI 10.1055/s-0035-1544634
Bibliografische Angaben
Nachweis in CareLit
Autor:innenJ Hohlfeld, A Furtwängler, M Könen-Bergmann, G Wallenstein, B Walter, ED Bateman
ZeitschriftPneumologie
Ausgabe02/2015
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: Extensive clinical trial data have shown that different doses of tiotropium, administered via either HandiHaler® 18 µg (HH18) or Respimat®, improves lung function, quality of life and reduces exacerbations in patients with chronic obstructive pulmonary disease (COPD); however, there is concern that antimuscarinic agents may induce cardiac arrhythmias in a vulnerable subpopulation of patients with cardiov…
Zitieren
Zitierempfehlung
J Hohlfeld, A Furtwängler, M Könen-Bergmann, G Wallenstein, B Walter, ED Bateman (2015) Evaluating cardiac safety of tiotropium in patients with COPD: Combined analysis of Holter-ECG data from four trials. Pneumologie (02). https://doi.org/10.1055/s-0035-1544634
Mit CareLit weiterarbeiten